Yaacov-Garbeli Dana 4
4 · Entera Bio Ltd. · Filed May 8, 2026
Research Summary
AI-generated summary of this filing
Entera Bio (ENTX) CFO Yaacov-Garbeli Dana Receives Award
What Happened Yaacov-Garbeli Dana, Chief Financial Officer of Entera Bio Ltd. (ENTX), was granted 58,394 stock-settled restricted stock units (RSUs) on May 7, 2026. The RSUs were awarded in lieu of a cash bonus and were granted at a $0.00 per-share acquisition price (total reported value $0). The RSUs vest ratably quarterly over a one-year period beginning May 1, 2026.
Key Details
- Transaction type: Award/Grant (Code A) on 2026-05-07; filing dated 2026-05-08.
- Amount: 58,394 RSUs granted; acquisition price reported as $0.00 (no cash paid).
- Vesting: Ratably each quarter over one year starting May 1, 2026.
- Shares owned after transaction: Not specified in the provided excerpt of the filing.
- Additional note: Footnote states the grant was approved by the Board and awarded in lieu of a cash bonus.
- Ownership disclosure: Footnote indicates the reporting person owns a 33.33% interest in A2Z Counseling Ltd., which holds certain Entera shares; the reporting person disclaims beneficial ownership of those A2Z-held securities except for any pecuniary interest.
- Timeliness: Filed the day after the reported transaction date; not indicated as late.
Context
- These RSUs are compensation, not an open-market purchase or sale; they convert into shares as they vest, so they do not signal an immediate buy or sell.
- For retail investors, awards like this reflect standard compensation practices and should be viewed differently from open-market insider purchases or sales.
Insider Transaction Report
Form 4
Entera Bio Ltd.ENTX
Yaacov-Garbeli Dana
Chief Financial Officer
Transactions
- Award
Ordinary Shares, par value NIS 0.0000769 per share
[F1][F2]2026-05-07+58,394→ 171,441 total(indirect: By A2Z Counseling Ltd.)
Footnotes (2)
- [F1]Represent a grant of stock-settled restricted stock units. This grant of stock-settled restricted stock units was approved by the Board of Directors (the "Board") of Entera Bio Ltd. (the "Company") on May 7, 2026. This grant was awarded to the Reporting Person in lieu of a cash bonus the Reported Person was otherwise entitled to. The restricted stock units vest ratably on a quarterly basis over a one-year period that began on May 1, 2026.
- [F2]These shares are owned by A2Z Counseling Ltd. of which the reporting person owns a 33.33% interest and has effective control over voting and disposition of the shares. The reporting person disclaims beneficial ownership of the securities held by A2Z Counseling Ltd., except to the extent of her pecuniary interest therein, if any, and this report shall not be deemed an admission that she is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Signature
/s/ Dana Yaacov-Garbeli|2026-05-08